Prospective Randomized 3-Arm Trial Comparing Tacrolimus with Mycophenolate Mofetil (MMF) or Sirolimus with Calcineurin inhibitor-Free Immunosuppression (Sirolimus/MMF) after Heart Transplantation

Trial Profile

Prospective Randomized 3-Arm Trial Comparing Tacrolimus with Mycophenolate Mofetil (MMF) or Sirolimus with Calcineurin inhibitor-Free Immunosuppression (Sirolimus/MMF) after Heart Transplantation

Active, no longer recruiting
Phase of Trial: Phase III

Latest Information Update: 09 Dec 2014

At a glance

  • Drugs Antithymocyte globulin; Methylprednisolone; Mycophenolate mofetil; Mycophenolate mofetil; Prednisone; Sirolimus; Tacrolimus; Tacrolimus
  • Indications Heart transplant rejection
  • Focus Therapeutic Use
  • Most Recent Events

    • 07 Nov 2012 5-year results presented at the 85th Annual Scientific Sessions of the American Heart Association.
    • 19 Jul 2012 5-year results presented at the 24th International Congress of the Transplantation Society.
    • 11 May 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top